Legal Representation
Attorney
Jeff Van Hoosear
USPTO Deadlines
Next Renewal Deadline
452 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2006-10-03)
Due Date
October 03, 2026
Grace Period Ends
April 03, 2027
Application History
39 events| Date | Code | Type | Description |
|---|---|---|---|
| May 26, 2017 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| May 26, 2017 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| May 26, 2017 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| May 26, 2017 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| Mar 31, 2017 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
| Oct 3, 2015 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| Feb 28, 2013 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Feb 28, 2013 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Feb 8, 2013 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Oct 1, 2012 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Sep 28, 2012 | E815 | I | TEAS SECTION 8 & 15 RECEIVED |
| Oct 3, 2006 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Aug 23, 2006 | REGV | O | LAW OFFICE REGISTRATION REVIEW COMPLETED |
| Aug 22, 2006 | ALIE | A | ASSIGNED TO LIE |
| Aug 16, 2006 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Aug 14, 2006 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Jul 17, 2006 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Jul 17, 2006 | IUAF | S | USE AMENDMENT FILED |
| Jun 14, 2006 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 14, 2006 | EXT3 | S | SOU EXTENSION 3 FILED |
| Jun 14, 2006 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Dec 22, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Dec 22, 2005 | EXT2 | S | SOU EXTENSION 2 FILED |
| Dec 22, 2005 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Jun 28, 2005 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 28, 2005 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jun 28, 2005 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jan 4, 2005 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Oct 12, 2004 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Sep 22, 2004 | NPUB | O | NOTICE OF PUBLICATION |
| Aug 17, 2004 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Aug 16, 2004 | ALIE | A | ASSIGNED TO LIE |
| Aug 5, 2004 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jul 28, 2004 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED |
| Jul 26, 2004 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jul 26, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| May 6, 2004 | DOCK | D | ASSIGNED TO EXAMINER |
| May 6, 2004 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Nov 10, 2003 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Reagents used in scientific and medical research
First Use Anywhere:
Jun 30, 2005
First Use in Commerce:
Jun 30, 2005
Class 005
Drugs, pharmaceuticals, cell preparations, vaccines and vaccine adjuvants, and other reagents used in the diagnosis, prevention, monitoring and treatment of disease, namely for cancer, infectious diseases, transplantation and immune disorders
First Use Anywhere:
Jun 30, 2005
First Use in Commerce:
Jun 30, 2005
Class 042
Medical and scientific research and development, namely, screening, evaluation, development and conducting clinical trials of therapeutic, preventative and diagnostic compositions and treatments
First Use Anywhere:
Jun 30, 2005
First Use in Commerce:
Jun 30, 2005
Additional Information
Pseudo Mark
INNATE PHARMACEUTICALS
Classification
International Classes
001
005
042